Please read and agree to the terms and conditions of this site.
@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
@techcrunch.com 6 years ago
GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
@techcrunch.com 7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT
@techcrunch.com 7 years ago
CRISPR loses Nobel to tiny machines
@techcrunch.com 7 years ago
Reshaping human health and changing lives through gene editing
@techcrunch.com 8 years ago
Innovation in genomics and the future of medtech
@techcrunch.com 8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute